Last week, the U.S. Court of Appeals for Second Circuit ruled that the Food and Drug Administration (FDA) cannot prosecute pharmaceutical manufacturers’ representatives for speech promoting the lawful, off-label use of an FDA-approved drug.  The... Read More
Drug and Device Advertising, Marketing & Promotion Legal Review | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Traditional Compounding Pharmacies (503A)

In the past year or two, hospitals have been in a feeding frenzy, buying medical practices one after the other. Primary care physicians, cardiologists, ob/gyns and a handful of other specialists have been the targets of these acquisitions. With... Read More
Healthcare Law